Cerebral Venous Sinus Thrombosis Clinical Trial
Official title:
Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment
This is a single-center, retrospective, open-label study. This study is planned to investigate the accuracy of mRS and NIHSS, comparing with the accuracy of CSF pressure and papilledema grade in assessing cerebral venous sinus thrombosis.
| Status | Recruiting |
| Enrollment | 100 |
| Est. completion date | July 1, 2018 |
| Est. primary completion date | April 1, 2018 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - confirmed diagnosis of CVST by head MRI, DSA or MRV onset of CVST within one month Exclusion Criteria: - unable to complete examinations unable to complete follow-ups |
| Country | Name | City | State |
|---|---|---|---|
| China | Xuanwu Hospital Capital Medical University | Beijing |
| Lead Sponsor | Collaborator |
|---|---|
| Capital Medical University |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | baseline CSF pressure | CSF pressure at baseline | baseline | |
| Primary | baseline mRS | mRS at baseline | baseline | |
| Primary | baseline papilledema grade | Frisen grade of papilledema at baseline | baseline | |
| Secondary | baseline NIHSS | NIH Stroke Scale at baseline | baseline |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04269954 -
The Efficacy and Safety of Batroxobin Combined With Anticoagulation in Cerebral Venous Sinus Thrombosis
|
Phase 4 | |
| Not yet recruiting |
NCT03919305 -
Cerebral Venous Thrombosis Cohort Study in China Mainland
|
||
| Recruiting |
NCT05291585 -
The Dedicated Venous Sinus Thrombectomy Stent for Endovascular Treatment of Cerebral Venous Sinus Thrombosis.
|
N/A | |
| Recruiting |
NCT04966182 -
Application CT and MRI in Cerebral Venous Sinus Thrombosis
|
||
| Recruiting |
NCT05021198 -
The Norwegian Cerebral Venous Thrombosis Study
|
||
| Withdrawn |
NCT04580238 -
Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
|
Phase 1 | |
| Completed |
NCT05448248 -
Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)
|